
It is important to use correct organization and appropriate methods for demonstrating biosimilar comparability to support regulatory filings.
Thomas A. Little, PhD, is president, Thomas A. Little Consulting and BioAssay Sciences, 12401 North Wildflower Lane, Highland, Utah 84003, USA, drlittle@dr-tom.com.

It is important to use correct organization and appropriate methods for demonstrating biosimilar comparability to support regulatory filings.

Pharmaceutical Technology's In the Lab eNewsletter
Bioassays are critical for determining drug substance and drug product potency, which is why it is important to understand the fundamentals of developing an effective bioassay.

December 4th 2019